LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Sender:
Lactation Information and Discussion <[log in to unmask]>
Date:
Tue, 13 Sep 2011 18:31:07 +1000
Reply-To:
Lactation Information and Discussion <[log in to unmask]>
Message-ID:
<[log in to unmask]>
Subject:
Re: Domperidone
MIME-Version:
1.0
Content-Transfer-Encoding:
7bit
In-Reply-To:
<[log in to unmask]>
Content-Type:
text/plain; charset="us-ascii"
From:
Karleen Gribble <[log in to unmask]>
Parts/Attachments:
text/plain (39 lines) 
Good on Tom and USLCA!
Karleen Gribble
Australia

-----Original Message-----
From: Lactation Information and Discussion
[mailto:[log in to unmask]] On Behalf Of [log in to unmask]
Sent: Tuesday, 13 September 2011 9:11 AM
To: [log in to unmask]
Subject: Domperidone

Below is the update on domperidone in the US provided by the US Lactation
Consultant Association. Please feel free to contact me if there are any
questions.


Marsha Walker, RN, IBCLC
Weston, MA


United States Lactation Consultant Association Announces

 
September 09, 2011 
 
Orphan drug designation obtained for Domerpidone in the US
 

             ***********************************************

Archives: http://community.lsoft.com/archives/LACTNET.html
To reach list owners: [log in to unmask]
Mail all list management commands to: [log in to unmask]
COMMANDS:
1. To temporarily stop your subscription write in the body of an email: set lactnet nomail
2. To start it again: set lactnet mail
3. To unsubscribe: unsubscribe lactnet
4. To get a comprehensive list of rules and directions: get lactnet welcome

ATOM RSS1 RSS2